Estimation of the Incremental Cumulative Cost of HIV Compared with a Non-HIV Population.

Cohen, Joshua P; Beaubrun, Anne; Ding, Yao; Wade, Rolin L; Hines, Dionne M

Cohen, Joshua P; Beaubrun, Anne; Ding, Yao; Wade, Rolin L; Hines, Dionne M.

Afiliação

Cohen JP; Center for the Study of Drug Development, Tufts University, Boston, MA, USA.
Beaubrun A; Division of Health Economics and Outcomes Research, Gilead Sciences, Foster City, CA, USA.
Ding Y; Department of Health Economics and Outcomes Research, Real-World Evidence, IQVIA, One IMS Drive, Plymouth Meeting, PA, 19462, USA.
Wade RL; Department of Health Economics and Outcomes Research, Real-World Evidence, IQVIA, One IMS Drive, Plymouth Meeting, PA, 19462, USA.
Hines DM; Department of Health Economics and Outcomes Research, Real-World Evidence, IQVIA, One IMS Drive, Plymouth Meeting, PA, 19462, USA. dionne.hines@iqvia.com.

Pharmacoecon Open ; 4(4): 687-696, 2020 Dec.

Article em En | MEDLINE | ID: mdl-32219732

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google